StockVS

Archimedes Tech SPAC Partners III Co. (ARCIU) Análise de ações

Serviços Financeiros

Archimedes Tech SPAC Partners III Co.

$10.08

+$0.03 (+0.30%)

Última atualização: 26 de maio de 2026

Histórico de Preços

Análise

Visão geral da empresa

Archimedes Tech SPAC Partners III Co. operates within the financial services sector, specifically functioning as a shell company dedicated to executing business combinations such as mergers, amalgamations, share exchanges, asset acquisitions, or reorganizations with one or more businesses. The entity was formally incorporated in 2025 and maintains its operational base in Claymont, Delaware, positioning it within the specialized niche of special purpose acquisition vehicles designed for future merger activity. Regarding the company's scale, the available data indicates a price-to-book ratio of -1111.11, while the market capitalization, annual revenue, and total employee count are currently listed as unavailable metrics in standard reporting databases. This absence of traditional valuation metrics like market cap and revenue highlights the transitional nature of shell companies, where financial size is often undefined until a definitive merger target is identified and consolidated assets are brought onto the balance sheet. Consequently, the lack of established revenue figures and employee headcount suggests that the company is in a pre-transaction phase where its market position is theoretical rather than operational, relying entirely on the eventual execution of a business combination to establish a tangible market footprint.

Saúde financeira

The financial statements for Archimedes Tech SPAC Partners III Co. report a net income of $-166,850 over the trailing twelve months, while revenue, EBITDA, and free cash flow are reported as unavailable or zero. The gap between the reported revenue (N/A) and the negative net income of $-166,850 reveals a cost structure where operating expenses, likely related to maintenance fees, legal reserves, or administrative overhead for the shell entity, exceed the minimal or non-existent operational revenue streams. Since free cash flow is listed as unavailable, the company's financial flexibility to fund pre-merger activities or pursue targets is not currently quantifiable through cash flow generation, relying instead on SPAC trust proceeds or external financing. The analysis of the three profit margins shows a gross margin of 0.0%, an operating margin of 0.0%, and a profit margin of 0.0%, indicating that the company is not yet generating revenue from a core product or service line that allows for profit scaling. In terms of leverage, the company's total cash and total debt figures are unavailable, preventing a direct comparison of liquidity against obligations, though the debt-to-equity ratio is also listed as unavailable. The current ratio stands at 0.11, which indicates a significant liquidity constraint where current liabilities substantially exceed current assets, a common characteristic for SPACs prior to merger completion that requires careful monitoring of cash reserves. Finally, the return on equity and return on assets are listed as unavailable due to the negative book value implied by the price-to-book ratio and the lack of positive earnings, suggesting that management effectiveness cannot be measured by traditional return metrics until a profitable operating business is acquired.

Avaliação de valorização

The trailing P/E ratio and forward P/E for Archimedes Tech SPAC Partners III Co. are both listed as unavailable, reflecting the fact that shell companies typically do not generate the consistent earnings required to calculate a meaningful price-to-earnings multiple before a merger is finalized. The price-to-book ratio is recorded at -1111.11, a figure that indicates a severe deviation from standard valuation norms where a positive book value is expected; this negative ratio suggests that the market capitalization, if it were to exist in a positive form, would be significantly lower than the negative shareholder equity, or that the data point reflects a specific accounting anomaly common in SPAC structures with negative net assets. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also unavailable, meaning these metrics cannot be used to benchmark the company against peers in the financial services sector or to assess its intrinsic value relative to sales generation. The stock price has traded within a range defined by a 52-week high of $10.15 and a 52-week low of $9.99, placing the current trading price extremely close to the lower bound of this historical range, specifically trading at approximately 1.5% below the 52-week high and 1.6% above the 52-week low. The beta value is listed as unavailable, which implies that the stock's volatility relative to the broader market cannot be statistically determined during the shell period, as price movements are often driven by SPAC-specific news and merger speculation rather than fundamental earnings volatility.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as unavailable, preventing an analysis of whether earnings are growing faster or slower than revenue, as the company has not yet generated a track record of sales growth from an operational business. Since the company is currently a shell entity with zero revenue and negative income, it does not qualify as a dividend payer, and therefore, there is no dividend yield or payout ratio to evaluate for sustainability. Instead of distributing cash to shareholders through dividends, the company reinvests any available liquidity or proceeds from its initial public offering into the search for and execution of a merger transaction to facilitate growth through acquisition. The overall growth and income profile for Archimedes Tech SPAC Partners III Co. is characterized by a lack of fundamental growth metrics and income distribution, with the primary value proposition resting on the potential of a future merger rather than current operational performance or cash returns.

Comparação com pares

Archimedes Tech SPAC Partners III Co. (ARCIU) atua no setor de Empresas de Fachada. Veja como se compara com seus pares mais próximos por capitalização de mercado:

Empresa Ticker Cap. de Mercado Índice P/L
Archimedes Tech SPAC Partners III Co. ARCIU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

O índice P/L médio do setor Empresas de Fachada é 82.8x. Archimedes Tech SPAC Partners III Co. é negociada a um P/L de N/A.

Esta análise é gerada por IA apenas para fins informativos e não constitui aconselhamento financeiro. Os dados podem estar atrasados ou imprecisos. Sempre faça sua própria pesquisa e consulte um consultor financeiro qualificado antes de tomar decisões de investimento.

Sobre Archimedes Tech SPAC Partners III Co.

Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.

A descrição da empresa é mostrada em inglês.

Visitar site →

Estatísticas Principais

Capitalização
N/A
Índice P/L
N/A
Máx. 52 Sem.
$10.15
Mín. 52 Sem.
$9.99
Volume Médio
14.51K

Dados fornecidos pelo Yahoo Finance via yfinance. Atualizado diariamente.

Informações da Empresa

Bolsa
NASDAQ
País
United States